Clinical Trials in Detroit

Showing 4961-4980 of 19,719 trials

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

NCT06212466

A prospective, multicenter, observational, single-arm trial to validate CardioFlux MCG's ability to diagnose myocardial ischemia caused by coronary microvascular dysfunction in patients with suspected ischemia and confirmed no obstructive coronary artery disease (suspected INOCA) by using diagnostic measures of coronary flow reserve (CFR) via invasive angiography as a reference standard for diagnosis.

Ischemic Heart DiseaseCoronary Microvascular DiseaseAngina+1 more

Genetesis Inc.136 participantsStarted Jun 2024

Gainesville, Florida, United States • Edgewood, Kentucky, United States • Detroit, Michigan, United States +5 more locations

COMPLETEDPhase 3< 1 mile

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

NCT04136366

The GUARD Trial is a multi-center, randomized, controlled, adaptive Phase 3 clinical trial of repeated intravitreal injections of ADX-2191 versus standard-of-care for the prevention of proliferative vitreoretinopathy.

Proliferative Vitreoretinopathy

Aldeyra Therapeutics, Inc.106 participantsStarted Nov 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Orlando, Florida, United States +20 more locations

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Find Trials by Condition in Detroit

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Lighting Intervention for Cancer-related Fatigue

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

RNS System NAUTILUS Study

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

A Study in Participants With Non-cirrhotic NASH With Fibrosis

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

AutoInflammatory Disease Alliance Registry (AIDA)